JP2009518410A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009518410A5 JP2009518410A5 JP2008544428A JP2008544428A JP2009518410A5 JP 2009518410 A5 JP2009518410 A5 JP 2009518410A5 JP 2008544428 A JP2008544428 A JP 2008544428A JP 2008544428 A JP2008544428 A JP 2008544428A JP 2009518410 A5 JP2009518410 A5 JP 2009518410A5
- Authority
- JP
- Japan
- Prior art keywords
- dsrna
- medicament according
- vaccine
- animal
- avian influenza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74290605P | 2005-12-07 | 2005-12-07 | |
| US75289805P | 2005-12-23 | 2005-12-23 | |
| US79323906P | 2006-04-20 | 2006-04-20 | |
| PCT/US2006/046356 WO2007067517A2 (en) | 2005-12-07 | 2006-12-06 | Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013013055A Division JP2013075920A (ja) | 2005-12-07 | 2013-01-28 | インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのｄｓＲＮＡ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009518410A JP2009518410A (ja) | 2009-05-07 |
| JP2009518410A5 true JP2009518410A5 (enExample) | 2010-02-25 |
Family
ID=38123418
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008544428A Pending JP2009518410A (ja) | 2005-12-07 | 2006-12-06 | インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのｄｓＲＮＡ |
| JP2013013055A Pending JP2013075920A (ja) | 2005-12-07 | 2013-01-28 | インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのｄｓＲＮＡ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013013055A Pending JP2013075920A (ja) | 2005-12-07 | 2013-01-28 | インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのｄｓＲＮＡ |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US7943147B2 (enExample) |
| EP (1) | EP1957101A4 (enExample) |
| JP (2) | JP2009518410A (enExample) |
| AU (1) | AU2006322073A1 (enExample) |
| CA (1) | CA2632516C (enExample) |
| WO (1) | WO2007067517A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060035859A1 (en) * | 2003-05-16 | 2006-02-16 | Hemispherx Biopharma | Treating severe and acute viral infections |
| WO2005009337A2 (en) * | 2003-05-16 | 2005-02-03 | Hemispherx Biopharma | Treating severe acute respiratory syndrome |
| JP2009518410A (ja) * | 2005-12-07 | 2009-05-07 | へミスフェリックス・バイオファーマ | インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのｄｓＲＮＡ |
| AU2008266910A1 (en) * | 2007-06-18 | 2008-12-24 | Hemispherx Biopharma, Inc. | Early intervention of viral infections with immune activators |
| JP5731198B2 (ja) | 2007-09-27 | 2015-06-10 | イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． | インビボでのポリヌクレオチドの送達のための連続疎水相を含む担体におけるリポソームの使用 |
| CA2715293A1 (en) * | 2008-02-15 | 2009-08-20 | Hemispherx Biopharma, Inc. | Selective agonist of toll-like receptor 3 |
| US20110110979A1 (en) * | 2008-04-16 | 2011-05-12 | Universite De Lausanne | Method and vaccine for optimizing the specific immune responses |
| AU2009253780B2 (en) * | 2008-06-05 | 2014-08-14 | Immunovaccine Technologies Inc. | Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
| US9603919B2 (en) | 2009-03-31 | 2017-03-28 | Japan As Represented By The Director-General Of National Institute Of Infectious Diseases | Method for prophylaxis of influenza using vaccine for intranasal administration |
| CN113876945A (zh) | 2011-10-06 | 2022-01-04 | 免疫疫苗技术有限公司 | 包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用 |
| CN114746114B (zh) * | 2019-08-28 | 2025-10-03 | 株式会社Na疫苗研究所 | 以新型核酸为基础的流感疫苗组合物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3906092A (en) | 1971-11-26 | 1975-09-16 | Merck & Co Inc | Stimulation of antibody response |
| US4024222A (en) * | 1973-10-30 | 1977-05-17 | The Johns Hopkins University | Nucleic acid complexes |
| US4349538A (en) * | 1979-12-07 | 1982-09-14 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid |
| CA1326450C (en) * | 1985-08-26 | 1994-01-25 | William A. Carter | Modulation of aids virus-related events by double stranded rnas (dsrnas) |
| US5132292A (en) * | 1990-05-25 | 1992-07-21 | Hem Research, Inc. | Treatment of viral hepatitis |
| US6589529B1 (en) * | 1998-10-30 | 2003-07-08 | Children's Hospital Medical Center | Rotavirus subunit vaccine |
| GB0119346D0 (en) * | 2001-08-08 | 2001-10-03 | Bioclones Proprietary Ltd | Process for the maturation of dendritic cells |
| CN103446582A (zh) | 2003-08-11 | 2013-12-18 | 财团法人阪大微生物病研究会 | 包含诱导粘膜免疫的佐剂的新型疫苗 |
| US7834064B2 (en) * | 2005-01-03 | 2010-11-16 | Andres Mario Salazar | Clinical method for the immunomodulatory and vaccine adjuvant use of poly-ICLC and other dsRNAs |
| JP2009518410A (ja) * | 2005-12-07 | 2009-05-07 | へミスフェリックス・バイオファーマ | インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのｄｓＲＮＡ |
| AU2008223446B2 (en) | 2007-03-05 | 2012-02-02 | Utah State University | Restrictive agonist of Toll-like receptor 3 (TLR3) |
-
2006
- 2006-12-06 JP JP2008544428A patent/JP2009518410A/ja active Pending
- 2006-12-06 AU AU2006322073A patent/AU2006322073A1/en not_active Abandoned
- 2006-12-06 EP EP06844824A patent/EP1957101A4/en not_active Withdrawn
- 2006-12-06 US US11/634,389 patent/US7943147B2/en active Active
- 2006-12-06 WO PCT/US2006/046356 patent/WO2007067517A2/en not_active Ceased
- 2006-12-06 CA CA2632516A patent/CA2632516C/en active Active
-
2011
- 2011-04-19 US US13/064,824 patent/US20110223198A1/en not_active Abandoned
-
2013
- 2013-01-28 JP JP2013013055A patent/JP2013075920A/ja active Pending
-
2014
- 2014-11-11 US US14/537,981 patent/US20150064216A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6378380B2 (ja) | ワクチン組成物 | |
| CY1122291T1 (el) | Αναστολeις ιικου αναδιπλασιασμου | |
| JP2013516450A5 (enExample) | ||
| JP2009511084A5 (enExample) | ||
| JP2009539965A5 (enExample) | ||
| Hayden | Advances in antivirals for non‐influenza respiratory virus infections | |
| JP2009518410A5 (enExample) | ||
| JP2011504486A5 (enExample) | ||
| Gasparini et al. | Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza Part II: Future compounds against influenza virus | |
| JP2013126989A5 (enExample) | ||
| FI3300743T3 (fi) | Menetelmiä rokotteen antamiseksi | |
| JP2012502037A5 (enExample) | ||
| Cai et al. | 14-Deoxy-11, 12-didehydroandrographolide attenuates excessive inflammatory responses and protects mice lethally challenged with highly pathogenic A (H5N1) influenza viruses | |
| Budimir et al. | Heterosubtypic cross‐protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration | |
| JP2010270130A5 (enExample) | ||
| JP2013503880A5 (enExample) | ||
| Kitano et al. | Efficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques | |
| KR20170055487A (ko) | 경피 투여용 백신 의약 조성물 | |
| Zheng et al. | In vitro screening of traditional Chinese medicines compounds derived with anti-encephalomyocarditis virus activities | |
| JP2009518410A (ja) | インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのｄｓＲＮＡ | |
| JP2016520077A5 (enExample) | ||
| JP2010528053A (ja) | インフルエンザ感染症を治療するための物質および方法 | |
| JP2014512353A5 (enExample) | ||
| CN111918870A (zh) | 氘代的低聚核苷酸及前体药物 | |
| Andreev et al. | Promising compounds from natural sources against COVID-19 |